Skip to main content

Marksans Pharma Ltd

NSE: MARKSANS BSE: 524404Pharma

Marksans Pharma Ltd (MARKSANS) is a Pharma company listed on NSE: MARKSANS | BSE: 524404. With a market cap of ₹9,829 Cr and ROCE of 18.6%, ROE of 14.4%, it operates in the Indian Pharma sector.

217
52W: ₹155 — ₹271
PE 39.8 · Book ₹33 · +558% vs book
Market Cap₹9,829 Cr
Stock P/E39.8Price to Earnings
ROCE18.6%Return on Capital
ROE14.4%Return on Equity
Div. Yield0.38%Face Value ₹1

Strengths

  • +Company is almost debt free.
  • +Company has delivered good profit growth of 37.7% CAGR over last 5 years
  • +Company has been maintaining a healthy dividend payout of 20.5%

Weaknesses

  • Company has a low return on equity of 12.4% over last 3 years.
  • Company has high debtors of 171 days.

Shareholding Pattern

Promoters43.87%
FIIs16.76%
DIIs6.57%
Public32.78%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters43.87%43.87%43.87%43.87%43.87%43.87%43.87%43.87%
FIIs18.59%21.31%2.721.95%0.622.19%0.219.89%2.316.92%3.08.13%8.816.76%8.6
DIIs3.75%4.1%0.34.3%0.24.55%0.35.5%1.05.28%0.25.91%0.66.57%0.7
Public33.77%30.7%3.129.88%0.829.37%0.530.74%1.433.93%3.242.08%8.132.78%9.3

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales205241225255309312299320320340
Expenses167199191213245252248250248264
Operating Profit37423441636052707275
OPM %18%17%15%16%21%19%17%22%22%22%
Net Profit312533326355384810061
EPS ₹0.690.560.730.711.391.220.831.062.21.34

AI Insights

Revenue Trend

TTM revenue at ₹1,279Cr, up 8.9% YoY. OPM at 21%.

Debt Position

Borrowings at ₹11Cr. Debt-to-equity ratio: 0.01x. Healthy balance sheet.

Institutional Flow

DIIs: 6.57% (+2.92pp change). FIIs: 16.76% (+1.86pp change). Promoters hold 43.87%.

Margin & Efficiency

ROCE declining from 35% (Mar 2014) to 19% (Mar 2025). Working capital days: 145.

Valuation

PE 39.8x with 18.6% ROCE. Price is 558% above book value of ₹33. Dividend yield: 0.38%.

Recent Announcements